Provided by Tiger Fintech (Singapore) Pte. Ltd.

West Pharmaceutical

215.13
+9.254.49%
Pre-market: 216.701.57+0.73%05:15 EDT
Volume:1.59M
Turnover:340.43M
Market Cap:15.55B
PE:32.16
High:216.98
Open:208.06
Low:207.25
Close:205.88
Loading ...

West Pharmaceutical Shares Fall 13% Premarket After Co Forecasts Annual Results Below Estimates

THOMSON REUTERS
·
13 Feb

West Pharmaceutical Q4 Adjusted Earnings Decline, Revenue Rises; Provides 2025 Guidance

MT Newswires Live
·
13 Feb

West Pharmaceutical: Q4 Earnings Snapshot

Associated Press Finance
·
13 Feb

West Pharmaceutical Services Inc: Fourth-Quarter 2024 Net Sales of $748.8 Mln

THOMSON REUTERS
·
13 Feb

West Pharmaceutical Servs Q4 2024 Adj. EPS $1.82 Beats $1.72 Estimate, Sales $748.800M Beat $740.471M Estimate

Benzinga
·
13 Feb

BRIEF-West Pharmaceutical Outlook FY Adjusted EPS USD 6-6.2

Reuters
·
13 Feb

West Pharmaceutical Outlook FY Adjusted EPS USD 6-6.2

THOMSON REUTERS
·
13 Feb

West Pharmaceutical Services (WST) Bounced Back in Q4

Insider Monkey
·
12 Feb

West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For

StockStory
·
12 Feb

Will Segmental Performance Drive West Pharmaceutical's Q4 Earnings?

Zacks
·
11 Feb

West Pharmaceutical Services Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
08 Feb

ASX Runners of the Week: KalGold, OzAurum, Ausquest & EQ Resources

The Sydney Morning Herald
·
07 Feb

Becton Dickinson (BDX) Tops Q1 Earnings and Revenue Estimates

Zacks
·
06 Feb

West Pharmaceutical Services Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
06 Feb

West Pharmaceutical Services Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
04 Feb

Pro-Dex, Inc. (PDEX) Surpasses Q2 Earnings and Revenue Estimates

Zacks
·
31 Jan

West to Host Fourth-Quarter and Full-Year 2024 Conference Call

PR Newswire
·
30 Jan

West Pharmaceutical Services Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
30 Jan

Press Release: West Announces First-Quarter Dividend

Dow Jones
·
29 Jan

West Pharmaceutical Services (NYSE:WST) shareholders have earned a 17% CAGR over the last five years

Simply Wall St.
·
25 Jan